Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Treasury Shares (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Treasury Shares for 5 consecutive years, with $6.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Treasury Shares rose 68.94% year-over-year to $6.6 million, compared with a TTM value of $6.6 million through Sep 2025, up 68.94%, and an annual FY2024 reading of $3.9 million, up 66.74% over the prior year.
  • Treasury Shares was $6.6 million for Q3 2025 at Lucid Diagnostics, roughly flat from $6.6 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $6.6 million in Q1 2025 and bottomed at $1.8 million in Q3 2023.
  • Average Treasury Shares over 5 years is $3.3 million, with a median of $2.3 million recorded in 2022.
  • The sharpest move saw Treasury Shares decreased 17.19% in 2023, then skyrocketed 186.59% in 2025.
  • Year by year, Treasury Shares stood at $1.9 million in 2021, then increased by 7.76% to $2.1 million in 2022, then increased by 11.76% to $2.3 million in 2023, then skyrocketed by 66.74% to $3.9 million in 2024, then surged by 68.94% to $6.6 million in 2025.
  • Business Quant data shows Treasury Shares for LUCD at $6.6 million in Q3 2025, $6.6 million in Q2 2025, and $6.6 million in Q1 2025.